“People who use drugs and children are among the most vulnerable in our society.” These words were shared by Professor Harry Hausler, CEO of TB HIV Care, as a delegation from the Global Fund Private Sector Delegation (PSD) visited two of the organization’s programs in South Africa. TB HIV Care puts integrated care at the heart of responding to TB, … Read More
Key Takeaways from 15th National Joint Annual Programme Review For HIV, Tuberculosis and Malaria in Nigeria
While Nigeria has made significant progress in the control of HIV, TB and malaria (ATM) over the last two decades, the three infectious diseases continue to constitute major public health problems in the country. Over the years, the country has established various platforms and mechanisms to review its performance in the three disease areas and offer policy and programmatic recommendations … Read More
Tuberculosis is top infectious killer despite significant progress
This past Monday, the World Health Organization (WHO) released its Global tuberculosis (TB) report for 2017. The report documents a roller-coaster of successes and failures in the effort to combat TB. While 53 million lives have been saved since 2000, the disease remains the world’s leading infectious killer. Director-General, Dr. Tedros calls for a different approach, one that parallels action … Read More
Crossing the Valleys of Death in TB: From Development to Roll-Out
By: Dr. Lucica Ditiu and Dr. Catharina Boehme The numbers speak for themselves. In 2015 alone: 1.8 million died from tuberculosis (TB); 10.4 million people fell ill with the disease; and An estimated 480,000 developed multidrug resistant-TB (MDR-TB). All of this, combined with the airborne transmission of the disease, makes TB the leading infectious disease killer (surpassing both HIV … Read More
Joining Global Forces to End TB
Today, March 24th, is World TB Day. World TB Day commemorates the day that Dr. Robert Koch announced his startling discovery of the cause of tuberculosis (TB). The discovery was a breakthrough and brought new hope to sufferers. More than 130 years on, it remains the world’s leading infectious killer. 1.8 million people worldwide died from the disease in 2015, … Read More
Whadya Know About TB?
Each year on March 24th, we celebrate World TB Day. Although tuberculosis (TB) is preventable and curable, it remains one of the top ten causes of death in the world.
A Global Discussion on Antimicrobial Resistance: An Interview Series
by Ian Matthews, Director, GBCHealth With the release in May of the final report and recommendations of the Review on Antimicrobial Resistance, GBCHealth has convened a group of global leaders to discuss the potential impact of AMR and their priorities for immediate action. The interview series, which will be published over the next three weeks, is intended to supplement the … Read More
Private Sector Doubles Contribution to Global Fund
Last week, the Global Fund to Fight AIDS, Tuberculosis and Malaria hosted its Fifth Replenishment Conference where government and private sector partners pledged a total of $12.9 billion for 2017-2019. This replenishment was particularly noteworthy for its inaugural commitments – such as a $10 million pledge from the Government of Qatar – and pledges from African countries and companies. Kenya and South Africa pledged … Read More
Spotlight on PSD Members – Eli Lilly, Johnson & Johnson, Sumitomo Chemical and Sanofi
In honor of World TB Day and World Malaria Day, we are highlighting some of the extraordinary work the PSD member companies are undertaking in the fight to end these epidemics. Read more about how Eli Lilly is bringing global attention to the TB-diabetes co-epidemic, Janssen’s partnership to expand access to a new MDR-TB drug, Sumitomo Chemical’s commitment to protect … Read More
World TB Day Interview with Dr. Lucica Ditiu, Executive Director of the StopTB Partnership
Dr. Lucica Ditiu, Executive Director of the StopTB Partnership, shares her priorities for greater private sector action on the Global Plan to End TB: The Paradigm Shift (2016-2020) — a 5-year investment plan to accelerate elimination of TB and reach the targets of the WHO End TB Strategy. The new Global Plan to End TB launched this year is called “The Paradigm Shift.” … Read More